Transcatheter Aortic Valve Implantation: Where are we in 2020?
Int. j. cardiovasc. sci. (Impr.)
; 33(5): 537-549, Sept.-Oct. 2020. tab, graf
Article
in En
| LILACS
| ID: biblio-1134402
Responsible library:
BR1.1
ABSTRACT
Abstract Aortic stenosis is an insidious disease of rapid progression after the onset of symptoms. Aortic valve replacement surgery is a well-established therapy that reduces symptoms and increases survival rates. However, the procedure may be associated with high operative mortality rates and promote comorbidity. Depending on the local reality, the prevalence of patients considered inoperable (due to medical comorbidities and age) may achieve 30%. For these patients, transcatheter aortic valve implantation (TAVI) was initially indicated; over time, the method has advanced technologically and been simplified, and become an alternative therapy for patients at low and intermediate surgical risk also, and considered one of the major advances of modern medicine.
Key words
Full text:
1
Collection:
01-internacional
Database:
LILACS
Main subject:
Aortic Valve Stenosis
/
Transcatheter Aortic Valve Replacement
Type of study:
Prevalence_studies
/
Risk_factors_studies
Language:
En
Journal:
Int. j. cardiovasc. sci. (Impr.)
/
International Journal of Cardiovascular Sciences (Online)
/
International journal of cardiovascular sciences (Impresso)
Journal subject:
CARDIOLOGIA
Year:
2020
Document type:
Article
Affiliation country:
Brasil
Country of publication:
Brasil